206 related articles for article (PubMed ID: 21334795)
21. Synthesis and evaluation of anticancer activity of some novel 6-aryl-2-(p-sulfamylphenyl)-pyridazin-3(2H)-ones.
Rathish IG; Javed K; Ahmad S; Bano S; Alam MS; Akhter M; Pillai KK; Ovais S; Samim M
Eur J Med Chem; 2012 Mar; 49():304-9. PubMed ID: 22305543
[TBL] [Abstract][Full Text] [Related]
22. Studies on the cytotoxic activity of synthetic 2H-azirine-2-azetidinone compounds.
Maia DP; Wilke DV; Mafezoli J; da Silva Júnior JN; de Moraes MO; Pessoa C; Costa-Lotufo LV
Chem Biol Interact; 2009 Jul; 180(2):220-5. PubMed ID: 19497420
[TBL] [Abstract][Full Text] [Related]
23. Synthesis, cytotoxicity, DNA interaction, and topoisomerase II inhibition properties of novel indeno[2,1-c]quinolin-7-one and indeno[1,2-c]isoquinolin-5,11-dione derivatives.
Ryckebusch A; Garcin D; Lansiaux A; Goossens JF; Baldeyrou B; Houssin R; Bailly C; Hénichart JP
J Med Chem; 2008 Jun; 51(12):3617-29. PubMed ID: 18507368
[TBL] [Abstract][Full Text] [Related]
24. Novel angular furoquinolinones bearing flexible chain as antitumor agent: design, synthesis, cytotoxic evaluation, and DNA-binding studies.
Xie L; Qian X; Cui J; Xiao Y; Wang K; Wu P; Cong L
Bioorg Med Chem; 2008 Sep; 16(18):8713-8. PubMed ID: 18722129
[TBL] [Abstract][Full Text] [Related]
25. Synthesis of some novel quinoline-3-carboxylic acids and pyrimidoquinoline derivatives as potential antimicrobial agents.
El-Sayed OA; Al-Bassam BA; Hussein ME
Arch Pharm (Weinheim); 2002 Nov; 335(9):403-10. PubMed ID: 12447913
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and antiproliferative activity in vitro of new propargyl thioquinolines.
Boryczka S; Wietrzyk J; Opolski A
Pharmazie; 2002 Mar; 57(3):151-4. PubMed ID: 11933840
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and c-Met kinase inhibition of 3,5-disubstituted and 3,5,7-trisubstituted quinolines: identification of 3-(4-acetylpiperazin-1-yl)-5-(3-nitrobenzylamino)-7- (trifluoromethyl)quinoline as a novel anticancer agent.
Wang Y; Ai J; Wang Y; Chen Y; Wang L; Liu G; Geng M; Zhang A
J Med Chem; 2011 Apr; 54(7):2127-42. PubMed ID: 21405128
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and antiproliferative evaluation of certain indolo[3,2-c]quinoline derivatives.
Lu CM; Chen YL; Chen HL; Chen CA; Lu PJ; Yang CN; Tzeng CC
Bioorg Med Chem; 2010 Mar; 18(5):1948-57. PubMed ID: 20171108
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and antitumor evaluation of analogues of the marine pyrroloiminoquinone tsitsikammamines.
Rives A; Le Calvé B; Delaine T; Legentil L; Kiss R; Delfourne E
Eur J Med Chem; 2010 Jan; 45(1):343-51. PubMed ID: 19897281
[TBL] [Abstract][Full Text] [Related]
30. Discovery and structure-activity relationship of N-phenyl-1H-pyrazolo[3,4-b]quinolin-4-amines as a new series of potent apoptosis inducers.
Zhang HZ; Claassen G; Crogran-Grundy C; Tseng B; Drewe J; Cai SX
Bioorg Med Chem; 2008 Jan; 16(1):222-31. PubMed ID: 17950608
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and antiproliferative evaluation of certain indeno[1,2-c]quinoline derivatives. Part 2.
Tseng CH; Tzeng CC; Yang CL; Lu PJ; Chen HL; Li HY; Chuang YC; Yang CN; Chen YL
J Med Chem; 2010 Aug; 53(16):6164-79. PubMed ID: 20662543
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and antiplasmodial activity of aminoalkylamino-substituted neocryptolepine derivatives.
El Sayed I; Van der Veken P; Steert K; Dhooghe L; Hostyn S; Van Baelen G; Lemière G; Maes BU; Cos P; Maes L; Joossens J; Haemers A; Pieters L; Augustyns K
J Med Chem; 2009 May; 52(9):2979-88. PubMed ID: 19364118
[TBL] [Abstract][Full Text] [Related]
33. New 5-substituted thiazolo[3,2-b][1,2,4]triazol-6-ones: synthesis and anticancer evaluation.
Lesyk R; Vladzimirska O; Holota S; Zaprutko L; Gzella A
Eur J Med Chem; 2007 May; 42(5):641-8. PubMed ID: 17303290
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of novel 3,5-diaryl pyrazole derivatives using combinatorial chemistry as inhibitors of tyrosinase as well as potent anticancer, anti-inflammatory agents.
Bandgar BP; Totre JV; Gawande SS; Khobragade CN; Warangkar SC; Kadam PD
Bioorg Med Chem; 2010 Aug; 18(16):6149-55. PubMed ID: 20638287
[TBL] [Abstract][Full Text] [Related]
35. Structure-activity relationships of highly cytotoxic copper(II) complexes with modified indolo[3,2-c]quinoline ligands.
Primik MF; Göschl S; Jakupec MA; Roller A; Keppler BK; Arion VB
Inorg Chem; 2010 Dec; 49(23):11084-95. PubMed ID: 20979395
[TBL] [Abstract][Full Text] [Related]
36. Quinols as novel therapeutic agents. 2.(1) 4-(1-Arylsulfonylindol-2-yl)-4-hydroxycyclohexa-2,5-dien-1-ones and related agents as potent and selective antitumor agents.
Berry JM; Bradshaw TD; Fichtner I; Ren R; Schwalbe CH; Wells G; Chew EH; Stevens MF; Westwell AD
J Med Chem; 2005 Jan; 48(2):639-44. PubMed ID: 15658878
[TBL] [Abstract][Full Text] [Related]
37. Triazolo[4,5-f]quinolines. Part VI. Synthesis and evaluation of 9-aminoalkyl(aryl)-2-methyl-2H-[4,5-f]quinolines as anticancer agents. Preliminary results of in vitro screening.
Sanna P; Sequi PA; Paglietti G
Farmaco; 1995 Jan; 50(1):47-54. PubMed ID: 7702720
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and biological evaluation of 4beta-[(4-substituted)-1,2,3-triazol-1-yl]podophyllotoxins as potential anticancer agents.
Reddy PB; Agrawal SK; Singh S; Bhat BA; Saxena AK; Kumar HM; Qazi GN
Chem Biodivers; 2008 Sep; 5(9):1792-802. PubMed ID: 18816530
[TBL] [Abstract][Full Text] [Related]
39. 5-Amino-2-aroylquinolines as highly potent tubulin polymerization inhibitors.
Nien CY; Chen YC; Kuo CC; Hsieh HP; Chang CY; Wu JS; Wu SY; Liou JP; Chang JY
J Med Chem; 2010 Mar; 53(5):2309-13. PubMed ID: 20148562
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, antiproliferative, and antiplatelet activities of oxime- and amide-containing quinolin-2(1H)-one derivatives.
Chen IL; Chang KM; Miaw CL; Liao CH; Chen JJ; Wang TC
Bioorg Med Chem; 2007 Oct; 15(20):6527-34. PubMed ID: 17689252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
